Gene Symbol | Gene ID | Gene Info |
---|---|---|
Otx1
|
ENSMUSG00000005917.9 | orthodenticle homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_22017536_22017834 | Otx1 | 14788 | 0.245365 | 0.89 | 1.7e-19 | Click! |
chr11_22004052_22004509 | Otx1 | 1383 | 0.523060 | 0.87 | 3.7e-18 | Click! |
chr11_21994299_21994805 | Otx1 | 7063 | 0.253794 | 0.85 | 2.9e-16 | Click! |
chr11_22007422_22007891 | Otx1 | 4759 | 0.284728 | 0.85 | 3.6e-16 | Click! |
chr11_22005339_22005726 | Otx1 | 2635 | 0.352954 | 0.84 | 6.1e-16 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_83720072_83720262 | 18.05 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1214 |
0.37 |
chr7_92985429_92985580 | 17.95 |
Gm31663 |
predicted gene, 31663 |
3452 |
0.23 |
chr5_147155070_147155280 | 17.77 |
Gsx1 |
GS homeobox 1 |
33521 |
0.11 |
chr18_45896851_45897467 | 17.73 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr16_42575508_42575977 | 17.12 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr3_120982893_120983085 | 16.92 |
Gm43444 |
predicted gene 43444 |
37787 |
0.16 |
chr15_91018414_91018934 | 14.58 |
Kif21a |
kinesin family member 21A |
31144 |
0.16 |
chr14_45581302_45581777 | 14.39 |
Gm15601 |
predicted gene 15601 |
6201 |
0.1 |
chr13_36283221_36283410 | 14.16 |
Gm48766 |
predicted gene, 48766 |
30956 |
0.17 |
chr13_39823707_39823913 | 13.63 |
A230103O09Rik |
RIKEN cDNA A230103O09 gene |
544 |
0.74 |
chr7_101772830_101772994 | 13.56 |
Clpb |
ClpB caseinolytic peptidase B |
9306 |
0.13 |
chr3_20776940_20777107 | 13.29 |
Gm18491 |
predicted gene, 18491 |
7040 |
0.19 |
chr13_42709181_42709490 | 13.26 |
Phactr1 |
phosphatase and actin regulator 1 |
208 |
0.96 |
chr3_120983890_120984270 | 13.25 |
Gm43444 |
predicted gene 43444 |
36696 |
0.17 |
chr19_14507172_14507352 | 13.20 |
Tle4 |
transducin-like enhancer of split 4 |
88277 |
0.1 |
chr1_168550282_168550460 | 13.09 |
Mir6348 |
microRNA 6348 |
59728 |
0.15 |
chr8_65966468_65966658 | 12.80 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
594 |
0.8 |
chr6_103307293_103307469 | 12.64 |
Gm44295 |
predicted gene, 44295 |
27395 |
0.24 |
chr7_79590405_79591230 | 12.55 |
Gm45169 |
predicted gene 45169 |
1796 |
0.2 |
chr3_49886660_49886837 | 12.54 |
Gm37550 |
predicted gene, 37550 |
105861 |
0.06 |
chr12_70367356_70367615 | 12.54 |
Trim9 |
tripartite motif-containing 9 |
19871 |
0.17 |
chr7_79526328_79526597 | 12.52 |
Mir9-3hg |
Mir9-3 host gene |
1388 |
0.23 |
chr5_13529424_13529638 | 12.41 |
Gm42676 |
predicted gene 42676 |
3808 |
0.23 |
chr7_49654672_49654823 | 12.36 |
Dbx1 |
developing brain homeobox 1 |
17898 |
0.23 |
chr3_153084641_153085060 | 12.35 |
1700094M23Rik |
RIKEN cDNA 1700094M23 gene |
90560 |
0.07 |
chr10_59958140_59958359 | 12.31 |
Ddit4 |
DNA-damage-inducible transcript 4 |
6415 |
0.18 |
chr11_24363754_24364273 | 12.31 |
Gm12068 |
predicted gene 12068 |
62233 |
0.12 |
chr7_51749650_51749828 | 12.30 |
Gm7336 |
predicted gene 7336 |
3092 |
0.24 |
chr7_54782252_54782424 | 12.30 |
Luzp2 |
leucine zipper protein 2 |
53160 |
0.15 |
chr18_73369664_73369876 | 12.29 |
n-R5-8s1 |
nuclear encoded rRNA 5.8S 1 |
163780 |
0.04 |
chr6_93792884_93793099 | 12.20 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
452 |
0.66 |
chr9_48678525_48678676 | 12.02 |
Nnmt |
nicotinamide N-methyltransferase |
73447 |
0.1 |
chr8_90536467_90536639 | 12.01 |
Gm45639 |
predicted gene 45639 |
138405 |
0.04 |
chr13_76802462_76802613 | 11.94 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
22670 |
0.24 |
chr3_55873315_55873490 | 11.85 |
Gm43376 |
predicted gene 43376 |
16904 |
0.19 |
chr6_73644786_73645257 | 11.81 |
Gm31747 |
predicted gene, 31747 |
36348 |
0.2 |
chr6_22794880_22795138 | 11.77 |
Gm25942 |
predicted gene, 25942 |
5191 |
0.17 |
chr3_17793443_17793892 | 11.67 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr3_120983132_120983283 | 11.52 |
Gm43444 |
predicted gene 43444 |
37569 |
0.16 |
chr6_124768348_124768568 | 11.51 |
Eno2 |
enolase 2, gamma neuronal |
82 |
0.9 |
chr18_45008987_45009151 | 11.46 |
Gm31706 |
predicted gene, 31706 |
35793 |
0.15 |
chr9_41285748_41285899 | 11.35 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
41254 |
0.12 |
chr15_8815380_8815535 | 11.35 |
Gm5043 |
predicted gene 5043 |
99027 |
0.07 |
chr8_61515184_61515647 | 11.33 |
Palld |
palladin, cytoskeletal associated protein |
485 |
0.84 |
chr9_40268412_40269319 | 11.30 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr11_43575984_43576172 | 11.29 |
Gm12150 |
predicted gene 12150 |
5038 |
0.16 |
chrX_110810424_110810578 | 11.25 |
Gm44593 |
predicted gene 44593 |
1823 |
0.4 |
chr1_165935548_165935799 | 11.19 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
662 |
0.64 |
chr11_114336197_114336398 | 11.15 |
Gm11692 |
predicted gene 11692 |
20832 |
0.21 |
chr11_111296488_111296797 | 11.09 |
Gm11675 |
predicted gene 11675 |
20542 |
0.29 |
chrX_152656185_152656553 | 11.06 |
Shroom2 |
shroom family member 2 |
11826 |
0.22 |
chr3_17326806_17327055 | 11.00 |
Gm30340 |
predicted gene, 30340 |
7495 |
0.24 |
chr7_73644446_73644645 | 10.82 |
Gm26176 |
predicted gene, 26176 |
1544 |
0.23 |
chr6_85165699_85166040 | 10.78 |
Spr-ps1 |
sepiapterin reductase pseudogene 1 |
10661 |
0.09 |
chr17_66480303_66480708 | 10.72 |
Rab12 |
RAB12, member RAS oncogene family |
19814 |
0.14 |
chr15_39391765_39391916 | 10.71 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
40 |
0.99 |
chr16_43130612_43130969 | 10.66 |
Gm25873 |
predicted gene, 25873 |
4557 |
0.28 |
chr6_144251546_144251744 | 10.64 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42077 |
0.21 |
chr14_64587864_64588052 | 10.61 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
93 |
0.96 |
chr2_105913737_105913920 | 10.58 |
Immp1l |
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
9190 |
0.18 |
chr3_134303047_134303415 | 10.54 |
Gm43559 |
predicted gene 43559 |
30721 |
0.13 |
chr6_142781097_142781248 | 10.44 |
Cmas |
cytidine monophospho-N-acetylneuraminic acid synthetase |
11206 |
0.17 |
chr3_102980219_102980386 | 10.40 |
Sike1 |
suppressor of IKBKE 1 |
15406 |
0.12 |
chr1_184905939_184906137 | 10.38 |
Gm38251 |
predicted gene, 38251 |
17098 |
0.16 |
chr5_146384860_146385320 | 10.36 |
Wasf3 |
WAS protein family, member 3 |
105 |
0.97 |
chr12_49394690_49395255 | 10.36 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
4313 |
0.15 |
chr12_117728160_117728414 | 10.30 |
Gm18955 |
predicted gene, 18955 |
4315 |
0.24 |
chr3_127750202_127750565 | 10.15 |
Gm23279 |
predicted gene, 23279 |
18789 |
0.1 |
chr1_81316963_81317114 | 10.13 |
Gm37210 |
predicted gene, 37210 |
205303 |
0.02 |
chr4_122999274_122999698 | 10.08 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
147 |
0.94 |
chr13_107540756_107541086 | 10.08 |
Gm32004 |
predicted gene, 32004 |
24402 |
0.2 |
chr2_19448091_19448577 | 10.05 |
Ptf1aos |
pancreas specific transcription factor 1a, opposite strand |
1660 |
0.24 |
chr3_139205801_139206419 | 9.99 |
Stpg2 |
sperm tail PG rich repeat containing 2 |
217 |
0.96 |
chr10_22609004_22609241 | 9.91 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr13_84906124_84906297 | 9.86 |
Gm4059 |
predicted gene 4059 |
68107 |
0.12 |
chr11_37153919_37154124 | 9.84 |
Tenm2 |
teneurin transmembrane protein 2 |
81861 |
0.12 |
chr11_16257044_16257441 | 9.81 |
Vstm2a |
V-set and transmembrane domain containing 2A |
482 |
0.85 |
chr5_84153090_84153587 | 9.80 |
Hmgn2-ps1 |
high mobility group nucleosomal binding domain 2, pseudogene 1 |
30025 |
0.25 |
chr10_51257840_51258054 | 9.72 |
Gm5040 |
predicted gene 5040 |
19118 |
0.23 |
chr8_54975155_54975306 | 9.71 |
Gm45263 |
predicted gene 45263 |
15411 |
0.14 |
chr1_98192584_98192735 | 9.71 |
Gm29461 |
predicted gene 29461 |
19011 |
0.19 |
chr4_32325987_32326153 | 9.69 |
Bach2it1 |
BTB and CNC homology 2, intronic transcript 1 |
74309 |
0.1 |
chr4_131432917_131433068 | 9.68 |
Gm831 |
predicted gene 831 |
54205 |
0.16 |
chr4_122998402_122999232 | 9.65 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr13_15544664_15544877 | 9.63 |
Gli3 |
GLI-Kruppel family member GLI3 |
80790 |
0.08 |
chr11_35873974_35874191 | 9.58 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
1630 |
0.4 |
chr10_27001616_27001786 | 9.56 |
Lama2 |
laminin, alpha 2 |
13187 |
0.21 |
chr4_64207477_64207852 | 9.50 |
8030451A03Rik |
RIKEN cDNA 8030451A03 gene |
59111 |
0.13 |
chr13_83984413_83984945 | 9.49 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr5_118706510_118706706 | 9.45 |
Gm43051 |
predicted gene 43051 |
794 |
0.62 |
chr17_56241606_56241788 | 9.37 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
19 |
0.93 |
chr9_110287438_110287789 | 9.35 |
Gm42775 |
predicted gene 42775 |
6324 |
0.11 |
chr6_73427372_73427523 | 9.32 |
Olfr210-ps1 |
olfactory receptor 210, pseudogene 1 |
6229 |
0.19 |
chr3_154172423_154172622 | 9.31 |
Gm42541 |
predicted gene 42541 |
33425 |
0.14 |
chr14_79771835_79772011 | 9.25 |
Pcdh8 |
protocadherin 8 |
611 |
0.64 |
chr14_29204763_29204914 | 9.23 |
Gm6043 |
predicted gene 6043 |
12801 |
0.21 |
chr12_55537902_55538053 | 9.22 |
Aldoart2 |
aldolase 1 A, retrogene 2 |
27262 |
0.14 |
chr15_27811126_27811398 | 9.20 |
Trio |
triple functional domain (PTPRF interacting) |
12521 |
0.21 |
chr2_65415400_65415551 | 9.20 |
Gm24138 |
predicted gene, 24138 |
39193 |
0.13 |
chr3_82357392_82357703 | 9.12 |
Map9 |
microtubule-associated protein 9 |
497 |
0.88 |
chr9_45651378_45651578 | 9.11 |
Gm22069 |
predicted gene, 22069 |
16666 |
0.18 |
chr9_10681606_10682000 | 9.10 |
Gm7529 |
predicted gene 7529 |
52837 |
0.17 |
chr6_8299171_8299359 | 9.02 |
Umad1 |
UMAP1-MVP12 associated (UMA) domain containing 1 |
28799 |
0.13 |
chr1_56834636_56834821 | 9.02 |
Satb2 |
special AT-rich sequence binding protein 2 |
135112 |
0.05 |
chr18_26489889_26490063 | 9.01 |
Gm23674 |
predicted gene, 23674 |
5459 |
0.35 |
chr8_55964851_55965002 | 8.92 |
Gm7351 |
predicted gene 7351 |
9293 |
0.2 |
chr2_5381837_5382302 | 8.92 |
Gm13197 |
predicted gene 13197 |
98419 |
0.07 |
chr19_26340291_26340442 | 8.89 |
Gm50377 |
predicted gene, 50377 |
31659 |
0.19 |
chr13_78581852_78582016 | 8.81 |
Gm48402 |
predicted gene, 48402 |
56083 |
0.14 |
chr3_109496606_109496769 | 8.80 |
Vav3 |
vav 3 oncogene |
1903 |
0.49 |
chr1_11748471_11748622 | 8.79 |
Gm38069 |
predicted gene, 38069 |
44339 |
0.2 |
chr15_41082521_41082910 | 8.71 |
Gm49524 |
predicted gene, 49524 |
84755 |
0.09 |
chr5_133983748_133984000 | 8.71 |
Gm2404 |
predicted gene 2404 |
63872 |
0.11 |
chrX_10992271_10992535 | 8.70 |
Gm14485 |
predicted gene 14485 |
28604 |
0.22 |
chr6_51057202_51057641 | 8.69 |
Gm44402 |
predicted gene, 44402 |
90153 |
0.08 |
chr8_44980136_44980492 | 8.67 |
Fat1 |
FAT atypical cadherin 1 |
30100 |
0.15 |
chr2_21283000_21283174 | 8.65 |
Gm13378 |
predicted gene 13378 |
38982 |
0.15 |
chr7_76185386_76185573 | 8.64 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44408 |
0.17 |
chr7_79534046_79534197 | 8.63 |
Gm35040 |
predicted gene, 35040 |
1922 |
0.17 |
chr15_63769035_63769240 | 8.60 |
Gm46499 |
predicted gene, 46499 |
8976 |
0.12 |
chr2_115131879_115132212 | 8.59 |
Gm28493 |
predicted gene 28493 |
3505 |
0.33 |
chr4_140246501_140247112 | 8.59 |
Igsf21 |
immunoglobulin superfamily, member 21 |
22 |
0.98 |
chr12_49374830_49375049 | 8.56 |
Gm34304 |
predicted gene, 34304 |
6946 |
0.14 |
chr7_51791046_51791247 | 8.53 |
Gm29296 |
predicted gene 29296 |
18420 |
0.16 |
chr7_67468707_67468874 | 8.51 |
Gm33926 |
predicted gene, 33926 |
24857 |
0.18 |
chr17_90086753_90087284 | 8.43 |
Nrxn1 |
neurexin I |
1122 |
0.65 |
chr18_79049027_79050094 | 8.42 |
Setbp1 |
SET binding protein 1 |
59831 |
0.15 |
chr7_61878205_61878373 | 8.39 |
Mir344 |
microRNA 344 |
425 |
0.75 |
chr14_8510709_8510908 | 8.36 |
Gm8416 |
predicted gene 8416 |
101891 |
0.06 |
chr18_81509336_81509702 | 8.34 |
Gm50412 |
predicted gene, 50412 |
29162 |
0.19 |
chr11_25704417_25704568 | 8.34 |
Gm23514 |
predicted gene, 23514 |
19352 |
0.26 |
chrX_93301856_93302148 | 8.32 |
Arx |
aristaless related homeobox |
15492 |
0.23 |
chr2_83813748_83813899 | 8.31 |
Fam171b |
family with sequence similarity 171, member B |
1187 |
0.44 |
chr7_119427405_119427572 | 8.30 |
Gp2 |
glycoprotein 2 (zymogen granule membrane) |
31782 |
0.12 |
chr3_127652160_127652345 | 8.29 |
Neurog2 |
neurogenin 2 |
19117 |
0.11 |
chr2_131847315_131847793 | 8.28 |
5330413P13Rik |
RIKEN cDNA 5330413P13 gene |
69 |
0.93 |
chr10_91881593_91881813 | 8.27 |
Gm31592 |
predicted gene, 31592 |
7126 |
0.31 |
chr14_63586134_63586323 | 8.27 |
Xkr6 |
X-linked Kx blood group related 6 |
20275 |
0.15 |
chr2_49628188_49628339 | 8.23 |
Kif5c |
kinesin family member 5C |
8965 |
0.25 |
chr11_81270736_81270887 | 8.23 |
4930527B05Rik |
RIKEN cDNA 4930527B05 gene |
114202 |
0.06 |
chr10_77008292_77008443 | 8.18 |
Gm35721 |
predicted gene, 35721 |
202 |
0.9 |
chr3_26153515_26153806 | 8.18 |
Nlgn1 |
neuroligin 1 |
353 |
0.93 |
chr17_6746187_6746434 | 8.13 |
Ezr |
ezrin |
3489 |
0.21 |
chr19_14435617_14435984 | 8.11 |
Tle4 |
transducin-like enhancer of split 4 |
159739 |
0.04 |
chr3_30416503_30416654 | 8.10 |
Gm37024 |
predicted gene, 37024 |
71848 |
0.08 |
chr13_84570826_84570982 | 8.10 |
Gm26913 |
predicted gene, 26913 |
120037 |
0.06 |
chr13_28775161_28775312 | 8.08 |
Gm17528 |
predicted gene, 17528 |
51887 |
0.13 |
chr4_114986445_114986936 | 8.07 |
Cmpk1 |
cytidine monophosphate (UMP-CMP) kinase 1 |
382 |
0.83 |
chr6_93913579_93913746 | 8.06 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
28 |
0.98 |
chr10_42834610_42834857 | 8.05 |
Gm26464 |
predicted gene, 26464 |
13966 |
0.13 |
chr3_62458622_62458788 | 8.01 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
13882 |
0.24 |
chr6_55444064_55444642 | 7.97 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
7625 |
0.21 |
chr15_44752045_44752255 | 7.95 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
130 |
0.73 |
chr1_120644442_120644750 | 7.95 |
2610027F03Rik |
RIKEN cDNA 2610027F03 gene |
22856 |
0.2 |
chr3_127694928_127695298 | 7.95 |
Gm16238 |
predicted gene 16238 |
2593 |
0.17 |
chr9_22707603_22707772 | 7.90 |
Bbs9 |
Bardet-Biedl syndrome 9 (human) |
28937 |
0.15 |
chr16_21665525_21665719 | 7.88 |
2510009E07Rik |
RIKEN cDNA 2510009E07 gene |
27609 |
0.17 |
chr4_6979601_6979810 | 7.87 |
Tox |
thymocyte selection-associated high mobility group box |
10778 |
0.28 |
chr2_40643754_40643928 | 7.84 |
Lrp1b |
low density lipoprotein-related protein 1B |
13547 |
0.29 |
chr4_141335224_141335761 | 7.83 |
Gm25690 |
predicted gene, 25690 |
10672 |
0.09 |
chr4_11579390_11579709 | 7.82 |
Fsbp |
fibrinogen silencer binding protein |
116 |
0.96 |
chr3_30219294_30219445 | 7.81 |
Gm38197 |
predicted gene, 38197 |
8325 |
0.18 |
chr12_33030107_33030284 | 7.80 |
Cdhr3 |
cadherin-related family member 3 |
22791 |
0.13 |
chr10_89873656_89873922 | 7.79 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
117 |
0.97 |
chr9_35411841_35412279 | 7.79 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
9068 |
0.16 |
chr14_79822476_79822755 | 7.78 |
Gm6999 |
predicted gene 6999 |
14097 |
0.16 |
chr2_33616683_33616884 | 7.77 |
Gm38011 |
predicted gene, 38011 |
2385 |
0.25 |
chr7_109231349_109231689 | 7.76 |
Gm45024 |
predicted gene 45024 |
7319 |
0.22 |
chr8_82004303_82004454 | 7.76 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
114059 |
0.06 |
chr17_6860510_6860926 | 7.75 |
Mir692-1 |
microRNA 692-1 |
34619 |
0.11 |
chr2_137706146_137706328 | 7.73 |
Gm14064 |
predicted gene 14064 |
42802 |
0.21 |
chr8_99414527_99414729 | 7.73 |
Cdh8 |
cadherin 8 |
1691 |
0.36 |
chr2_25460257_25461283 | 7.72 |
Paxx |
non-homologous end joining factor |
106 |
0.9 |
chr2_61663689_61663846 | 7.71 |
Tank |
TRAF family member-associated Nf-kappa B activator |
19936 |
0.19 |
chr1_193433813_193434005 | 7.70 |
Gm38022 |
predicted gene, 38022 |
41381 |
0.11 |
chr6_82296750_82296962 | 7.69 |
Gm44209 |
predicted gene, 44209 |
26127 |
0.2 |
chr2_4099013_4099176 | 7.69 |
Gm38085 |
predicted gene, 38085 |
4783 |
0.13 |
chr1_94502083_94502408 | 7.67 |
Gm7895 |
predicted gene 7895 |
32358 |
0.23 |
chr18_49474794_49474945 | 7.63 |
1700044K03Rik |
RIKEN cDNA 1700044K03 gene |
48420 |
0.17 |
chr14_75566269_75566669 | 7.63 |
Cby2 |
chibby family member 2 |
25480 |
0.19 |
chr6_80623069_80623298 | 7.62 |
Gm44231 |
predicted gene, 44231 |
31846 |
0.23 |
chr15_59041366_59041517 | 7.61 |
Mtss1 |
MTSS I-BAR domain containing 1 |
844 |
0.66 |
chr13_84399447_84399679 | 7.58 |
Gm26927 |
predicted gene, 26927 |
59450 |
0.13 |
chr12_46818855_46819029 | 7.58 |
Nova1 |
NOVA alternative splicing regulator 1 |
13 |
0.98 |
chr4_5798150_5798378 | 7.58 |
Fam110b |
family with sequence similarity 110, member B |
180 |
0.97 |
chr12_26733908_26734059 | 7.57 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
100876 |
0.07 |
chr10_39558637_39558788 | 7.55 |
Gm16364 |
predicted gene 16364 |
650 |
0.7 |
chr13_18855949_18856160 | 7.54 |
Vps41 |
VPS41 HOPS complex subunit |
11191 |
0.23 |
chr1_118321665_118322443 | 7.54 |
Nifk |
nucleolar protein interacting with the FHA domain of MKI67 |
98 |
0.96 |
chr8_30921424_30921593 | 7.53 |
Gm45252 |
predicted gene 45252 |
82400 |
0.1 |
chr12_7029541_7029692 | 7.50 |
Gm46311 |
predicted gene, 46311 |
62656 |
0.16 |
chr14_24841794_24842145 | 7.48 |
Gm47906 |
predicted gene, 47906 |
8334 |
0.26 |
chr2_145859511_145860521 | 7.47 |
Rin2 |
Ras and Rab interactor 2 |
2628 |
0.24 |
chr3_79417407_79417581 | 7.44 |
Fnip2 |
folliculin interacting protein 2 |
48711 |
0.13 |
chr8_78550170_78550321 | 7.43 |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
27506 |
0.16 |
chr14_68981312_68981674 | 7.42 |
Stc1 |
stanniocalcin 1 |
47745 |
0.13 |
chr1_137373621_137374166 | 7.40 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr8_127552928_127553088 | 7.39 |
Gm6921 |
predicted pseudogene 6921 |
8427 |
0.23 |
chr4_72381380_72381531 | 7.38 |
Gm11235 |
predicted gene 11235 |
161211 |
0.04 |
chr10_39133560_39134579 | 7.36 |
Tube1 |
tubulin, epsilon 1 |
1 |
0.66 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.9 | 8.8 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.6 | 5.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.3 | 6.9 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.3 | 20.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.1 | 6.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.0 | 5.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.9 | 5.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.9 | 7.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.7 | 7.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.7 | 5.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.6 | 8.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.5 | 6.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 4.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.4 | 4.3 | GO:0042938 | dipeptide transport(GO:0042938) |
1.3 | 4.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.3 | 9.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.2 | 5.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.2 | 8.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.2 | 3.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.1 | 4.5 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 10.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.0 | 4.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.0 | 7.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.0 | 3.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.0 | 2.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 4.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.9 | 3.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 4.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 2.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 2.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 4.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.9 | 12.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.8 | 3.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.8 | 2.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.8 | 2.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 1.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.8 | 2.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.8 | 2.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 2.4 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 2.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.8 | 1.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 6.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 16.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 4.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 1.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.7 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 1.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.7 | 4.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.7 | 2.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 2.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 3.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.7 | 3.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 7.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 2.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.7 | 1.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.7 | 2.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 2.7 | GO:0046959 | habituation(GO:0046959) |
0.7 | 2.7 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 2.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 6.6 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.7 | 2.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 3.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 3.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.6 | 7.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.6 | 1.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 1.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 1.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 2.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 4.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.6 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 2.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 2.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.6 | 6.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 2.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.6 | 2.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 2.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 2.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.5 | 0.5 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 2.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 3.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 2.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 1.6 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 9.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.5 | 1.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 4.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 4.4 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 4.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 2.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 2.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 1.9 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 1.9 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 3.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 1.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 0.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.5 | 2.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 0.9 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 0.4 | GO:0048880 | sensory system development(GO:0048880) |
0.4 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 1.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.4 | 1.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 2.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.4 | 1.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 2.5 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.4 | 34.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 2.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 | 0.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 0.8 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 1.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 1.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 1.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 0.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 6.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 0.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 2.9 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.4 | 0.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 0.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 1.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 2.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 4.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.3 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 0.3 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 2.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 3.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 3.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 2.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.3 | 2.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.9 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 2.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 2.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 0.8 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 3.6 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 7.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 1.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 1.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 1.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.5 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.3 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 2.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 2.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 1.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.2 | 1.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 2.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 0.2 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.2 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 1.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 2.8 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.7 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 1.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.5 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 1.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 2.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 2.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 6.1 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.2 | 2.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 1.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.4 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.5 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 2.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.8 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.2 | 0.5 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.2 | 0.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 10.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 1.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.5 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 1.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 2.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 1.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 2.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.1 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 2.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 2.4 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.1 | 0.6 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.5 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.2 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 2.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 2.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 2.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.5 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 4.8 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 1.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.5 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 2.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.3 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 1.1 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 2.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 3.0 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 1.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 2.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 5.7 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 2.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.7 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.1 | 2.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 1.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.1 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.3 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.0 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.0 | 1.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.0 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.3 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.0 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.0 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.0 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.0 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.1 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.0 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) ductus arteriosus closure(GO:0097070) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.0 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.8 | 19.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.8 | 5.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.7 | 3.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.7 | 8.4 | GO:0000235 | astral microtubule(GO:0000235) |
1.4 | 4.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.3 | 8.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 6.0 | GO:0097433 | dense body(GO:0097433) |
1.1 | 4.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.0 | 8.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.9 | 3.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 6.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 10.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 10.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 5.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 5.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 3.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 4.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.6 | 15.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 14.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 8.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 5.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 14.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 1.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 2.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 2.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 3.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 2.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.3 | 4.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 12.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 0.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 2.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.7 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.1 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 16.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 2.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 2.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 2.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 4.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 1.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 17.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 5.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 4.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 2.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 2.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 6.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 8.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.3 | 6.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.3 | 11.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.9 | 9.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.8 | 5.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 4.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.5 | 4.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.4 | 6.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 3.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.9 | 10.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 4.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 2.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 6.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 6.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 4.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 2.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 0.7 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 2.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.7 | 2.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 2.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 2.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 4.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 4.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 2.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 2.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 7.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 5.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 3.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 2.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.6 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.6 | 6.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.6 | 2.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 2.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 6.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 3.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 2.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 1.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 10.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 1.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 3.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 2.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 2.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 1.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 8.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 5.2 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 0.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 3.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 10.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 2.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 1.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 2.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 6.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.3 | 1.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 2.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 5.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 3.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 1.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 3.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 2.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 2.1 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 2.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 4.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 3.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.4 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.0 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 1.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 1.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.3 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 2.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 3.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 4.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.6 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 6.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.3 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 1.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 6.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 2.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.1 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 2.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 3.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.7 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 2.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 2.1 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 7.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 10.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 4.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 3.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 5.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 2.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 3.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 3.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 5.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 3.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 9.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 16.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.2 | 1.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.9 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.8 | 8.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 3.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 5.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 3.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 9.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 3.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 7.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 5.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 2.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 4.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 1.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 3.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 3.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 5.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 3.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 2.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 5.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 2.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 2.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 2.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.0 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |